Santhera expands AGAMREE distribution deal with Biomedica to five markets

The widened agreement adds Georgia, Kazakhstan, Belarus, Azerbaijan and Uzbekistan, potentially opening access for about 2,000 Duchenne muscular dystrophy patients aged two and older.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.